Abstract: Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same.
| # | Name | Date |
|---|---|---|
| 1 | 202317033071-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [10-05-2023(online)].pdf | 2023-05-10 |
| 2 | 202317033071-STATEMENT OF UNDERTAKING (FORM 3) [10-05-2023(online)].pdf | 2023-05-10 |
| 3 | 202317033071-Sequence Listing in txt [10-05-2023(online)].txt | 2023-05-10 |
| 4 | 202317033071-Sequence Listing in PDF [10-05-2023(online)].pdf | 2023-05-10 |
| 5 | 202317033071-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [10-05-2023(online)].pdf | 2023-05-10 |
| 6 | 202317033071-FORM 1 [10-05-2023(online)].pdf | 2023-05-10 |
| 7 | 202317033071-DRAWINGS [10-05-2023(online)].pdf | 2023-05-10 |
| 8 | 202317033071-DECLARATION OF INVENTORSHIP (FORM 5) [10-05-2023(online)].pdf | 2023-05-10 |
| 9 | 202317033071-COMPLETE SPECIFICATION [10-05-2023(online)].pdf | 2023-05-10 |
| 10 | 202317033071.pdf | 2023-05-13 |
| 11 | 202317033071-FORM-26 [17-07-2023(online)].pdf | 2023-07-17 |
| 12 | 202317033071-Proof of Right [13-10-2023(online)].pdf | 2023-10-13 |
| 13 | 202317033071-FORM 3 [13-10-2023(online)].pdf | 2023-10-13 |
| 14 | 202317033071-FORM 18 [16-09-2024(online)].pdf | 2024-09-16 |